We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Antioxidants Treat Smith-Lemli-Opitz Syndrome

News   Feb 05, 2018 | By Ellen Goldbaum for University at Buffalo

 
Evidenced-Based Antioxidant Therapy Prevents Vision Loss Caused by Smith-Lemli-Opitz Syndrome

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

 
 
Advertisement
 

RELATED ARTICLES

Shorter Sleep Leads to Less Joy From Positive Experiences

News

New research finds that after a night of shorter sleep, people react more emotionally to stressful events the next day and don't find as much joy in the good things.

READ MORE

PTSD Could Double Risk of Dementia in Later Life

News

People who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life, according to a new study by UCL researchers.

READ MORE

AI Technique Copies Human Memory To Minimize Data Storage Burden

News

Artificial intelligence (AI) experts at the University of Massachusetts Amherst and the Baylor College of Medicine report that they have successfully addressed what they call a "major, long-standing obstacle to increasing AI capabilities" by drawing inspiration from a human brain memory mechanism known as "replay."

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE